Active ShortageTier 3 — Critical

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

OMEGA LABORATORIES LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP in Canada?

Yes. BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG has an active shortage reported to Health Canada (last updated September 11, 2026).

Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP be available again?

The manufacturer's estimated resolution date is March 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file3 products · 0 same form & route

Expected resolution~5 months remaining (estimate)

Affected strength7.5MG

Report last updated2026-09-11

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

BUPIVACAINE HYDROCHLORIDE INJECTION, USP

BAXTER CORPORATION

7.5MG · DIN 02488930

Same strengthSame dosage formDifferent routeNo current shortage

Compare these two →

SENSORCAINE

ASPEN PHARMACARE CANADA INC.

2.5MG · DIN 01976141

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

BUPIVACAINE INJECTION BP

STERIMAX INC

2.5MG · DIN 02443686

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02512424

Strength

7.5MG

Dosage Form

SOLUTION

Route

INTRASPINAL

Active Ingredient

BUPIVACAINE HYDROCHLORIDE

See all BUPIVACAINE HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-11

Active Shortage

Disruption of the manufacture of the drug.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413